10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia ...

FDA Drug Recall #D-1043-2018 — Class II — July 24, 2018

Recall Summary

Recall Number D-1043-2018
Classification Class II — Moderate risk
Date Initiated July 24, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm PharMEDium Services, LLC
Location Dayton, NJ
Product Type Drugs
Quantity 230 Intravia Bags

Product Description

10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 100 mL in 150 mL Intravia Bag, PharMEDium Services, LLC.

Reason for Recall

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Distribution Pattern

Product was distributed throughout the United States

Lot / Code Information

Lot 181760013D, 181730007D, Exp 08/09/2018, 09/02/2018

Other Recalls from PharMEDium Services, LLC

Recall # Classification Product Date
D-1087-2020 Class II rocuronium Bromide, 10 mg per mL, 50 mg per 5 m... Mar 16, 2020
D-1088-2020 Class II ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL ... Mar 16, 2020
D-1085-2020 Class II fentaNYL Citrate 10 mcg per mL, 2,500 mcg per 2... Mar 16, 2020
D-1082-2020 Class II nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9%... Mar 16, 2020
D-1083-2020 Class II rocuronium Bromide 10 mg per mL 50 mg per 5 mL,... Mar 16, 2020

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.